Skip to main content
Clinical Trials/NL-OMON24321
NL-OMON24321
Recruiting
Not Applicable

sing Continuous Glucose Monitoring and contextual data to increase insight in glucose patterns for individuals with type 2 diabetes

TNO0 sites40 target enrollmentTBD
ConditionsType 2 diabetes

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Type 2 diabetes
Sponsor
TNO
Enrollment
40
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
TNO

Eligibility Criteria

Inclusion Criteria

  • BMI 25 – 40 kg/m2, with preference for \< 35 kg/m2
  • Diagnosed with type 2 diabetes mellitus
  • Insulin naïve
  • Using either lifestyle and/or metformin for managing their diabetes
  • In possession of a Smartphone running on a recent version of iOS or Android
  • Able and willing to sign the informed consent form
  • Willing to comply with all study procedures

Exclusion Criteria

  • Insufficient motivation to be in the study
  • Unavailability for more than 2 weeks in a row during the study period
  • History of bariatric weight loss surgery
  • Planned (bariatric) surgery in the upcoming 6 months
  • Active cancer or chemotherapy or radiation within 2 years prior to participation
  • Chronic medical condition, treatment, or medication other than diabetes that may affect glucose metabolism (HIV diagnosis, use of steroids or immunosuppressive drugs, etc.)
  • Chronic anaemia (haemoglobin of 6\.2 mmol/l or less)
  • Use of antibiotics or fertility treatments within 3 months prior to participation
  • Pregnancy or a pregnancy wish
  • 4 or more alcoholic drinks per day on a regular basis or use of recreational drugs

Outcomes

Primary Outcomes

Not specified

Similar Trials